The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer
- 1 June 1996
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 14 (2-3) , 207-217
- https://doi.org/10.1016/0169-5002(96)00547-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prognostic factors in lung cancer: tables and commentsEuropean Respiratory Journal, 1994
- Neural Cell Adhesion Molecule and Prognosis of Surgically Resected Lung CancerAmerican Review of Respiratory Disease, 1993
- Antigen retrieval by microwave irradiation lowers immunohistological detection thresholdsHistopathology, 1993
- Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Neuroectodermal tumors of the peripheral and the central nervous system share neuroendocrine N-CAM-related antigens with small cell lung carcinomasActa Neuropathologica, 1991
- An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissuesCancer Letters, 1991
- Neuroendocrine phenotype, chemosensitivity and prognosis in adenocarcinoma of the lungAnnals of Oncology, 1991
- NCAM: a surface marker for human small cell lung cancer cellsFEBS Letters, 1990
- Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features.Journal of Clinical Oncology, 1989
- Embryonic neural cell adhesion molecules on human natural killer cellsEuropean Journal of Immunology, 1989